Danaher Corp

NYSE:DHRUnited States

Danaher Corporation designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company’s Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables and services that are used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. Its Life Sciences segment offers a range of instruments and consumables that are used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies, and test and manufacture new drugs, and vaccines. Its Diagnostics segment offers clinical instruments, reagents, consumables, software that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease.

Contact Information

Headquarters

2200 Pennsylvania Ave NW Ste 800WWASHINGTON, DC, United States 20037-1731

Phone

202-828-0850

Fax

202-828-0860

Executives

Chairman of the Board

Steven Rales

President, Chief Executive Officer, Director

Rainer Blair

Co-Founder, Director

Mitchell Rales

Chief Financial Officer, Executive Vice President

Matthew McGrew

Executive Vice President

Joakim Weidemanis